Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors

NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) o...

Full description

Saved in:
Bibliographic Details
Published inMediators of Inflammation Vol. 2013; no. 2013; pp. 263 - 274-124
Main Authors Hromadnikova, Ilona, Pirkova, Petra, Sedlackova, Lucie
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Limiteds 01.01.2013
Hindawi Puplishing Corporation
Hindawi Publishing Corporation
John Wiley & Sons, Inc
Wiley
Subjects
Online AccessGet full text
ISSN0962-9351
1466-1861
1466-1861
DOI10.1155/2013/405295

Cover

Loading…
Abstract NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3−CD56+ cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
AbstractList NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3 − CD56 + cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by [CD3.sup.-] [CD56.sup.+] cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKRP1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL2/TKD. The diverse effect of IL-2 or IL15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3−CD56+ cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity. Using flow cytometry the effect of in vitro stimulation with IL-2 or IL-15 alone or in combination with Hsp70-derived 14-mer peptide (TKD) on cell surface expression of NK activatory receptors (CD16, NKG2D, NKG2C, NKp46, NKp44, NKp30, KIR2DL4, DNAM-1, and LAMP1) and NK inhibitory receptors (NKG2A, KIR2DL2/L3, LIR1/ILT-2, and NKR-P1A) in healthy individuals was studied. Results were expressed as the percentage of receptor expressing cells and the amount of receptor expressed by CD3(-)CD56(+) cellular population. CD94, NKG2D, NKp44, NKp30, KIR2DL4, DNAM-1, LAMP1, NKG2A, and NKR-P1A were upregulated after the stimulation with IL-2 or IL-15 alone or in combination with TKD. KIR2DL2/L3 was upregulated only by IL-15 and IL-15/TKD. Concurrently, an increase in a number of NK cells positive for CD94, NKp44, NKp30, KIR2DL4, and LAMP1 was observed. IL-15 and IL-15/TKD caused also cell number rise positive for KIR2DL2/L3 and NKR-P1A. Cell number positive for NKG2C and NKG2A was increased only by IL-2 and IL-2/TKD. The diverse effect of IL-2 or IL-15 w or w/o TKD on cell surface expression was observed in CD16, NKp46, and LIR1/ILT-2.
Audience Academic
Author Pirkova, Petra
Sedlackova, Lucie
Hromadnikova, Ilona
AuthorAffiliation Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic
AuthorAffiliation_xml – name: Department of Molecular Biology and Cell Pathology, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 100 00 Prague, Czech Republic
Author_xml – sequence: 1
  fullname: Hromadnikova, Ilona
– sequence: 2
  fullname: Pirkova, Petra
– sequence: 3
  fullname: Sedlackova, Lucie
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23476104$$D View this record in MEDLINE/PubMed
BookMark eNqFkktv1DAQgCNURB9w4gyyxKWA0vrt-IK02ha6agUVKlwtJ5l0XWXtxclu6Q_if-Js2opWlVAOo7G_-Tx2Zjfb8sFDlr0m-IAQIQ4pJuyQY0G1eJbtEC5lTgpJtrIdrCXNNRNkO9vtuiuMseC8eJFtU8aVJJjvZH9mvmlX4CtAoUEzj366PgY0O8spCnGIRKBJm04cUufRNCxK523vgkfXrp-jk26ZK5wfQXRrqBHh-QIiOodl72pA-xenR-9RYvs5oOPfywhdN5Smw76eoim0LZpUvVvbPsQbZH2depi70m3S71AlTYjdy-x5Y9sOXt3GvezH5-OL6Ul-9u3LbDo5y63kvM8tLbTQlRaKWVIwbnXRlI3khSqEKpkQolGggQGwRODaipoIamWpWKq3nO1ls9FbB3tlltEtbLwxwTqzWQjx0tjYu6oFUwAnSpc0CRqugVrdFFUy2oqxRlKbXJ9G13JVLqCuwPfRtg-kD3e8m5vLsDZMFAVRIgn2bwUx_FpB15uF66r0YtZDWHWGMCKxkIyQhL4b0UubWnO-CclYDbiZMKW0VpQP1METVPpqWLgq_eLGpfUHBW__vcJ973fjkwAyAlUMXRehMZXrN7ORzK41BJthRM0womYc0VTz8VHNnfZp-sNIz52v7bX7D_xmhCEh0Nh7mEvN5XCf83Hfuuh6Z67CKvo0T-Y8WdJbUoUx2xgJHYLCDFOM6eNEJkhxQyhnfwF4Iw3g
CitedBy_id crossref_primary_10_1002_JLB_6RI0917_390R
crossref_primary_10_1007_s43032_023_01372_z
crossref_primary_10_1097_MPH_0000000000000303
crossref_primary_10_18632_oncotarget_18185
crossref_primary_10_3389_fimmu_2021_816499
crossref_primary_10_1111_aji_12374
crossref_primary_10_3389_fimmu_2016_00066
crossref_primary_10_1016_j_biopha_2023_114257
crossref_primary_10_3892_etm_2017_4562
crossref_primary_10_1155_2016_2085871
crossref_primary_10_3390_jcm9061816
crossref_primary_10_1097_CMR_0000000000000289
crossref_primary_10_1371_journal_pone_0151535
crossref_primary_10_1128_JVI_00235_18
crossref_primary_10_1016_j_canlet_2023_216462
crossref_primary_10_3390_ijms20184588
crossref_primary_10_1111_imm_12516
crossref_primary_10_3892_or_2021_8183
crossref_primary_10_1189_jlb_5A0116_053RR
crossref_primary_10_1158_2326_6066_CIR_17_0279
crossref_primary_10_1007_s00432_022_04532_x
crossref_primary_10_3389_fimmu_2022_767530
Cites_doi 10.4049/jimmunol.169.8.4253
10.1016/0092-8674(89)90606-5
10.4049/jimmunol.172.2.972
10.1084/jem.190.10.1505
10.1385/IR:35:3:263
10.1002/eji.200425418
10.4049/jimmunol.174.4.2152
10.1084/jem.186.7.1129
10.1038/370151a0
10.1038/icb.2008.5
10.1002/art.27677
10.1007/s00262-009-0680-0
10.1111/j.1365-2249.2004.02686.x
10.1074/jbc.270.24.14679
10.1146/annurev.immunol.22.012703.104711
10.1084/jem.20021127
10.4049/jimmunol.182.2.829
10.1158/1078-0432.CCR-03-0683
10.1111/j.1365-3083.2010.02395.x
10.1016/S0301-472X(98)00055-1
10.1006/geno.2000.6163
10.4049/jimmunol.170.9.4572
10.1038/nri2154
10.1002/eji.1830270612
10.1038/370153a0
10.1084/jem.170.2.481
10.1016/j.jim.2004.08.008
10.1155/MI/2006/46957
10.4049/jimmunol.171.4.1768
10.1186/1479-5876-7-50
10.4049/jimmunol.171.12.6611
10.1038/sj.icb.7100031
10.1016/j.jri.2005.12.008
10.1007/s00018-011-0797-0
10.1038/ni1581
10.1073/pnas.92.2.377
10.4049/jimmunol.161.7.3493
10.1093/neuonc/nop009
10.4049/jimmunol.176.4.2397
10.1034/j.1399-0039.2003.00037.x
10.1158/0008-5472.CAN-11-1565
10.4049/jimmunol.176.10.6270
10.1126/science.8079170
10.1016/j.exphem.2010.02.006
10.4049/jimmunol.168.7.3155
10.1007/s12192-007-0008-y
10.4049/jimmunol.153.6.2417
10.1016/S0021-9258(18)50638-4
10.1182/blood-2002-04-1251
10.1016/j.humimm.2010.06.015
10.1038/sj.onc.1202525
10.1016/1074-7613(95)90140-X
10.1182/blood.V98.3.705
10.1016/j.coi.2004.07.010
10.1038/308693a0
10.1007/s002510050276
10.2217/imt.11.102
10.1016/S0022-1759(02)00084-4
10.1016/j.cellimm.2008.08.007
10.1007/s002510050362
10.1016/1074-7613(95)90013-6
10.4049/jimmunol.158.9.4341
10.1016/S1074-7613(02)00427-2
10.1074/jbc.M601786200
10.4049/jimmunol.171.7.3415
10.1038/ni1487
10.4049/jimmunol.171.10.5277
10.1002/eji.200737266
10.1038/ni1524
10.1159/000205907
ContentType Journal Article
Contributor Pirkova, Petra
Sedlackova, Lucie
Contributor_xml – sequence: 1
  fullname: Pirkova, Petra
– sequence: 2
  fullname: Sedlackova, Lucie
Copyright Copyright © 2013 Ilona Hromadnikova et al.
COPYRIGHT 2013 John Wiley & Sons, Inc.
Copyright © 2013 Ilona Hromadnikova et al. 2013
Copyright_xml – notice: Copyright © 2013 Ilona Hromadnikova et al.
– notice: COPYRIGHT 2013 John Wiley & Sons, Inc.
– notice: Copyright © 2013 Ilona Hromadnikova et al. 2013
DBID 188
ADJCN
AHFXO
RHU
RHW
RHX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1155/2013/405295
DatabaseName Airiti Library
الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals
معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete
Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE




MEDLINE - Academic

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1466-1861
Editor Fantuzzi, Giamila
Editor_xml – sequence: 1
  givenname: Giamila
  surname: Fantuzzi
  fullname: Fantuzzi, Giamila
EndPage 274-124
ExternalDocumentID oai_doaj_org_article_8e4179b2152f49e2a9f8cda5ac33f62a
PMC3588175
A377997241
23476104
10_1155_2013_405295
469461
P20160527003_201312_201703020022_201703020022_263_274_124
Genre Journal Article
GroupedDBID ---
188
24P
29M
2UF
2WC
36B
4.4
53G
5GY
5VS
AAFWJ
AAJEY
ABDBF
ACGFO
ACIHN
ADBBV
ADRAZ
AEAQA
AENEX
AFPKN
AHMBA
AINHJ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BCNDV
CEFSP
CNMHZ
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
GROUPED_DOAJ
GX1
H13
HYE
IAO
IGS
IHR
IL9
INH
INR
ITC
KQ8
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
RHU
RHX
RNS
RPM
SV3
TR2
TUS
UZ5
WOQ
WOW
~8M
3V.
7X7
88E
8FE
8FH
8FI
8FJ
8G5
ABUWG
ADJCN
AFKRA
AHFXO
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
DWQXO
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
IPNFZ
LK8
M1P
M2O
M7P
OVD
PIMPY
PQQKQ
PROAC
PSQYO
RIG
TEORI
UKHRP
RHW
0R~
AAYXX
ACCMX
ACUHS
CITATION
OVT
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PQGLB
7X8
5PM
ID FETCH-LOGICAL-a644t-a28959c9573a1834a98fbf6487857b3555f7e9e3ee373a0da5d152a6b73644a43
IEDL.DBID M48
ISSN 0962-9351
1466-1861
IngestDate Wed Aug 27 01:30:31 EDT 2025
Thu Aug 21 14:11:23 EDT 2025
Fri Jul 11 04:24:58 EDT 2025
Wed Mar 19 02:06:37 EDT 2025
Sat Mar 08 18:52:42 EST 2025
Mon Jul 21 05:43:43 EDT 2025
Tue Jul 01 03:54:30 EDT 2025
Thu Apr 24 22:58:27 EDT 2025
Sun Jun 02 18:55:34 EDT 2024
Tue Nov 26 16:44:22 EST 2024
Tue Oct 01 22:52:01 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2013
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
http://creativecommons.org/licenses/by/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a644t-a28959c9573a1834a98fbf6487857b3555f7e9e3ee373a0da5d152a6b73644a43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: Giamila Fantuzzi
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1155/2013/405295
PMID 23476104
PQID 1316056311
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_8e4179b2152f49e2a9f8cda5ac33f62a
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3588175
proquest_miscellaneous_1316056311
gale_infotracmisc_A377997241
gale_infotracacademiconefile_A377997241
pubmed_primary_23476104
crossref_citationtrail_10_1155_2013_405295
crossref_primary_10_1155_2013_405295
hindawi_primary_10_1155_2013_405295
emarefa_primary_469461
airiti_journals_P20160527003_201312_201703020022_201703020022_263_274_124
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-01-01
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – month: 01
  year: 2013
  text: 2013-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Cairo, Egypt
PublicationPlace_xml – name: Cairo, Egypt
– name: United States
PublicationTitle Mediators of Inflammation
PublicationTitleAlternate Mediators Inflamm
PublicationYear 2013
Publisher Hindawi Limiteds
Hindawi Puplishing Corporation
Hindawi Publishing Corporation
John Wiley & Sons, Inc
Wiley
Publisher_xml – name: Hindawi Limiteds
– name: Hindawi Puplishing Corporation
– name: Hindawi Publishing Corporation
– name: John Wiley & Sons, Inc
– name: Wiley
References (10) 2011; 3
(17) 1994; 370
(11) 2008; 13
(14) 1998; 161
(36) 2003; 171
(33) 2002; 169
(5) 2006; 176
(2) 1997; 158
(63) 1998; 12
(4) 2004; 172
(70) 2006; 281
(37) 2010; 71
(55) 2010; 12
(51) 2007; 8
(19) 1989; 170
(25) 1989; 59
(34) 2003; 197
(49) 1995; 92
(29) 2007; 85
(16) 1995; 2
(58) 1998; 47
(8) 1987; 78
(71) 2011; 71
(27) 1979; 254
(45) 1994; 153
(18) 1995; 2
(59) 2005; 174
(48) 2004; 22
(20) 2003; 61
(35) 2003; 171
(65) 2002; 17
(74) 2009; 254
(41) 1997; 186
(12) 2006; 2006
(60) 2004; 172
(62) 1997; 27
(53) 2003; 101
(64) 2009; 182
(46) 2011; 68
(50) 2007; 8
(38) 2009; 58
(28) 1995; 270
(40) 2005; 139
(66) 2002; 264
(52) 2002; 168
(15) 1994; 370
(69) 2006; 4
(72) 2010; 62
(6) 2004; 10
(47) 2007; 7
(57) 2003; 171
(21) 2003; 170
(44) 2000; 65
(24) 1994; 265
(26) 1984; 308
(42) 1999; 190
(73) 2004; 294
(56) 2012; 8
(67) 2006; 70
(30) 2008; 86
(1) 1999; 18
(39) 2004; 34
(54) 2010; 38
(68) 2006; 176
(7) 2009; 23
(13) 2006; 35
(23) 2010; 71
(31) 2004; 16
(22) 2007; 37
(3) 1999; 27
(9) 2008; 9
(61) 2001; 98
(43) 1997; 46
(32) 2003; 171
44
47
49
50
51
53
10
54
11
55
12
13
58
15
17
1
3
6
7
9
61
62
20
65
22
66
23
67
25
28
29
70
71
73
30
74
31
34
37
39
40
41
42
43
References_xml – volume: 59
  start-page: 827
  issue: 5
  year: 1989
  end-page: 836
  ident: 25
  article-title: Synergistic activation by the glutamine-rich domains of human transcription factor Sp1
– volume: 171
  start-page: 3415
  issue: 7
  year: 2003
  end-page: 3425
  ident: 35
  article-title: KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN- production
– volume: 174
  start-page: 2152
  issue: 4
  year: 2005
  end-page: 2159
  ident: 59
  article-title: GATA-3 is an important transcription factor for regulating human NKG2A gene expression
– volume: 139
  start-page: 287
  issue: 2
  year: 2005
  end-page: 296
  ident: 40
  article-title: Effects of prolactin and cortisol on natural killer (NK) cell surface expression and function of human natural cytotoxicity receptors (NKp46, NKp44 and NKp30)
– volume: 170
  start-page: 4572
  issue: 9
  year: 2003
  end-page: 4577
  ident: 21
  article-title: TGF- 1 supresses myeloid Fc receptor function by regulating the expression and function of the common -subunit
– volume: 265
  start-page: 1573
  issue: 5178
  year: 1994
  end-page: 1577
  ident: 24
  article-title: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
– volume: 2
  start-page: 321
  issue: 4
  year: 1995
  end-page: 329
  ident: 16
  article-title: Identification and purification of human stat proteins activated in response to interleukin-2
– volume: 8
  start-page: 66
  issue: 1
  year: 2012
  end-page: 78
  ident: 56
  article-title: DNA demethylation and histone H3K9 acetylation determine the active transcription of the NKG2D gene in human CD8 (+) T and NK cells
– volume: 18
  start-page: 3648
  issue: 24
  year: 1999
  end-page: 3651
  ident: 1
  article-title: Oncogenic potential of Hsp72
– volume: 13
  start-page: 221
  issue: 2
  year: 2008
  end-page: 230
  ident: 11
  article-title: Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells
– volume: 22
  start-page: 405
  year: 2004
  end-page: 429
  ident: 48
  article-title: The dynamic life of natural killer cells
– volume: 172
  start-page: 2152
  issue: 4
  year: 2004
  end-page: 2159
  ident: 60
  article-title: IL-21 induces the functional maturation of murine NK cells
– volume: 171
  start-page: 5277
  issue: 10
  year: 2003
  end-page: 5286
  ident: 57
  article-title: Human CD94 gene expression: dual promoters differing in responsiveness to IL-2 or IL-15
– volume: 98
  start-page: 705
  issue: 3
  year: 2001
  end-page: 713
  ident: 61
  article-title: Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
– volume: 169
  start-page: 4253
  issue: 8
  year: 2002
  end-page: 4261
  ident: 33
  article-title: Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells
– volume: 171
  start-page: 1768
  issue: 4
  year: 2003
  end-page: 1774
  ident: 36
  article-title: KIR2DL4 (CD158d) genotype influences expression and function in NK cells
– volume: 70
  start-page: 33
  issue: 1-2
  year: 2006
  end-page: 42
  ident: 67
  article-title: Expression patterns of lectin-like natural killer receptors, inhibitory CD94/NKG2A, and activating CD94/NKG2C on decidual CD56bright natural killer cells differ from those on peripheral CD56dim natural killer cells
– volume: 254
  start-page: 149
  issue: 2
  year: 2009
  end-page: 154
  ident: 74
  article-title: Relationship between CD107a expression and cytotoxic activity
– volume: 186
  start-page: 1129
  issue: 7
  year: 1997
  end-page: 1136
  ident: 41
  article-title: p46, a novel natural killer cell-specific surface molecule that mediates cell activation
– volume: 182
  start-page: 829
  issue: 2
  year: 2009
  end-page: 836
  ident: 64
  article-title: IL-12-dependent inducible expression of the CD94/NKG2A inhibitory receptor regulates CD94/NKG2C+ NK cell function
– volume: 17
  start-page: 487
  issue: 4
  year: 2002
  end-page: 499
  ident: 65
  article-title: TCR specificity dictates CD94/NKG2A expression by human CTL
– volume: 281
  start-page: 28731
  issue: 39
  year: 2006
  end-page: 28736
  ident: 70
  article-title: Identification and characterization of the CD226 gene promoter
– volume: 65
  start-page: 129
  issue: 2
  year: 2000
  end-page: 136
  ident: 44
  article-title: A sequence-ready physical map of the region containing human natural killer gene complex on chromosome 12p12.3-p13.2
– volume: 9
  start-page: 495
  issue: 5
  year: 2008
  end-page: 502
  ident: 9
  article-title: Up on the tightrope: natural killer cell activation and inhibition
– volume: 197
  start-page: 245
  issue: 2
  year: 2003
  end-page: 255
  ident: 34
  article-title: DNA methylation maintains allele-specific KIR gene expression in human natural killer cells
– volume: 171
  start-page: 6611
  issue: 12
  year: 2003
  end-page: 6620
  ident: 32
  article-title: Transcriptional regulation of ILT family receptors
– volume: 47
  start-page: 305
  issue: 4
  year: 1998
  end-page: 309
  ident: 58
  article-title: Structure of the human CD94 C-type lectin gene
– volume: 34
  start-page: 3028
  issue: 11
  year: 2004
  end-page: 3038
  ident: 39
  article-title: The corticosteroid-induced inhibitory effect on NK cell function reflects down-regulation and/or dysfunction of triggering receptors involved in natural cytotoxicity
– volume: 264
  start-page: 109
  issue: 1-2
  year: 2002
  end-page: 119
  ident: 66
  article-title: Differential expression of inhibitory and activating CD94/NKG2 receptors on NK cell clones
– volume: 294
  start-page: 15
  issue: 1-2
  year: 2004
  end-page: 22
  ident: 73
  article-title: CD107a as a functional marker for the identification of natural killer cell activity
– volume: 38
  start-page: 351
  issue: 5
  year: 2010
  end-page: 362
  ident: 54
  article-title: Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression
– volume: 153
  start-page: 2417
  issue: 6
  year: 1994
  end-page: 2428
  ident: 45
  article-title: Human NKR-P1A: a disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes
– volume: 58
  start-page: 1691
  issue: 10
  year: 2009
  end-page: 1700
  ident: 38
  article-title: Anti-cancer activity and mechanistic features of a NK cell activating molecule
– volume: 2
  start-page: 689
  issue: 6
  year: 1995
  end-page: 697
  ident: 18
  article-title: Components of a Stat recognition code: evidence for two layers of molecular selectivity
– volume: 308
  start-page: 693
  issue: 5961
  year: 1984
  end-page: 698
  ident: 26
  article-title: The role of protein kinase C in cell surface signal transduction and tumour promotion
– volume: 168
  start-page: 3155
  issue: 7
  year: 2002
  end-page: 3164
  ident: 52
  article-title: Syk regulation of phosphoinositide 3-kinase-dependent NK cell function
– volume: 370
  start-page: 153
  issue: 6485
  year: 1994
  end-page: 157
  ident: 17
  article-title: Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells
– volume: 71
  start-page: 942
  issue: 10
  year: 2010
  end-page: 949
  ident: 23
  article-title: LILRB1 polymorphism and surface phenotypes of natural killer cells
– volume: 16
  start-page: 626
  issue: 5
  year: 2004
  end-page: 633
  ident: 31
  article-title: Killer immunoglobulin-like receptors
– volume: 46
  start-page: 307
  issue: 4
  year: 1997
  end-page: 311
  ident: 43
  article-title: The human natural killer gene complex is located on chromosome 12p12-p13
– volume: 172
  start-page: 972
  issue: 2
  year: 2004
  end-page: 980
  ident: 4
  article-title: The cell surface-localized heat shock protein 70 epitope TKD induces migration and cytolytic activity selectively in human NK cells
– volume: 3
  start-page: 1143
  issue: 10
  year: 2011
  end-page: 1166
  ident: 10
  article-title: NK cells: immune cross-talk and therapeutic implications
– volume: 4
  start-page: 573
  issue: 6
  year: 2006
  end-page: 581
  ident: 69
  article-title: DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes
– volume: 12
  start-page: 1165
  issue: 5
  year: 1998
  end-page: 1170
  ident: 63
  article-title: Differential regulation of human NK cell-associated gene expression following activation by IL-2, IFN-X and PMA/ionomycin
– volume: 27
  start-page: 470
  issue: 3
  year: 1999
  end-page: 478
  ident: 3
  article-title: Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells
– volume: 170
  start-page: 481
  issue: 2
  year: 1989
  end-page: 497
  ident: 19
  article-title: Alternative membrane forms of Fc RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions
– volume: 35
  start-page: 263
  issue: 3
  year: 2006
  end-page: 277
  ident: 13
  article-title: The CD94/NKG2 family of receptors
– volume: 61
  start-page: 189
  issue: 3
  year: 2003
  end-page: 202
  ident: 20
  article-title: Fc R polymorphisms: implications for function, disease susceptibility and immunotherapy
– volume: 176
  start-page: 6270
  issue: 10
  year: 2006
  end-page: 6276
  ident: 5
  article-title: Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells
– volume: 270
  start-page: 14679
  issue: 24
  year: 1995
  end-page: 14684
  ident: 28
  article-title: Low affinity binding of phorbol esters to protein kinase C and its recombinant cysteine-rich region in the absence of phospholipids
– volume: 78
  start-page: 75
  issue: 1
  year: 1987
  end-page: 76
  ident: 8
  article-title: Therapy of cancer using the adoptive transfer of activated killer cells and interleukin-2
– volume: 23
  issue: 7, article 50
  year: 2009
  ident: 7
  article-title: Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy: a case report
– volume: 68
  start-page: 3519
  issue: 21
  year: 2011
  end-page: 3529
  ident: 46
  article-title: Regulation of immune cell function and differentiation by the NKG2D receptor
– volume: 8
  start-page: 1345
  issue: 12
  year: 2007
  end-page: 1352
  ident: 51
  article-title: NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
– volume: 85
  start-page: 220
  issue: 3
  year: 2007
  end-page: 228
  ident: 29
  article-title: Activation-induced upregulation of inhibitory killer Ig-like receptors is regulated by protein kinase C
– volume: 86
  start-page: 372
  issue: 4
  year: 2008
  end-page: 380
  ident: 30
  article-title: Amino-acid sequence motifs for PKC-mediated membrane trafficking of the inhibitory killer Ig-like receptor
– volume: 71
  start-page: 6410
  issue: 20
  year: 2011
  end-page: 6418
  ident: 71
  article-title: IRF-1 expression is essential for natural killer cells to suppress metastasis
– volume: 158
  start-page: 4341
  issue: 9
  year: 1997
  end-page: 4350
  ident: 2
  article-title: Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells
– volume: 37
  start-page: 2912
  issue: 10
  year: 2007
  end-page: 2922
  ident: 22
  article-title: Functional role of phosphatidylcholine-specific phospholipase C in regulating CD16 membrane expression in natural killer cells
– volume: 92
  start-page: 377
  issue: 2
  year: 1995
  end-page: 381
  ident: 49
  article-title: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor chain
– volume: 8
  start-page: 856
  issue: 8
  year: 2007
  end-page: 863
  ident: 50
  article-title: Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1
– volume: 12
  start-page: 7
  issue: 1
  year: 2010
  end-page: 13
  ident: 55
  article-title: TGF- downregulates the activating receptor NKG2D on NK cells and CD8 T cells in glioma patients
– volume: 10
  start-page: 3699
  issue: 11
  year: 2004
  end-page: 3707
  ident: 6
  article-title: Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial
– volume: 254
  start-page: 3692
  issue: 10
  year: 1979
  end-page: 3695
  ident: 27
  article-title: Calcium-dependent activation of a multifunctional protein kinase by membrane phospholipids
– volume: 71
  start-page: 413
  issue: 6
  year: 2010
  end-page: 419
  ident: 37
  article-title: Identification of the amino acid sequence motif for conventional PKC-mediated regulation of NKp46 surface expression
– volume: 62
  start-page: 3404
  issue: 11
  year: 2010
  end-page: 3414
  ident: 72
  article-title: A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus
– volume: 2006
  year: 2006
  end-page: 6
  ident: 12
  article-title: Influence of interleukin IL-2 and IL-12 + IL-18 on surface expression of immunoglobulin-like receptors KIR2DL1, KIR2DL2, and KIR3DL2 in natural killer cells
– volume: 161
  start-page: 3493
  issue: 7
  year: 1998
  end-page: 3500
  ident: 14
  article-title: Differential transcriptional regulation of and a novel gene, , by IL-2, IL-15, and IL-12 in NK and T cells
– volume: 190
  start-page: 1505
  issue: 10
  year: 1999
  end-page: 1516
  ident: 42
  article-title: Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
– volume: 370
  start-page: 151
  issue: 6485
  year: 1994
  end-page: 153
  ident: 15
  article-title: Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
– volume: 7
  start-page: 703
  issue: 9
  year: 2007
  end-page: 714
  ident: 47
  article-title: Developmental pathways that generate natural-killer-cell diversity in mice and humans
– volume: 27
  start-page: 1374
  issue: 6
  year: 1997
  end-page: 1380
  ident: 62
  article-title: Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor
– volume: 101
  start-page: 236
  issue: 1
  year: 2003
  end-page: 244
  ident: 53
  article-title: Regulation of Akt-dependent cell survival by Syk and Rac
– volume: 176
  start-page: 2397
  issue: 4
  year: 2006
  end-page: 2406
  ident: 68
  article-title: CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase
– volume: 169
  start-page: 4253
  issue: 8
  year: 2002
  ident: 33
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.169.8.4253
– ident: 25
  doi: 10.1016/0092-8674(89)90606-5
– volume: 172
  start-page: 972
  issue: 2
  year: 2004
  ident: 4
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.172.2.972
– ident: 42
  doi: 10.1084/jem.190.10.1505
– ident: 13
  doi: 10.1385/IR:35:3:263
– ident: 39
  doi: 10.1002/eji.200425418
– volume: 174
  start-page: 2152
  issue: 4
  year: 2005
  ident: 59
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.174.4.2152
– volume: 8
  start-page: 66
  issue: 1
  year: 2012
  ident: 56
  publication-title: Epigenetics
– ident: 41
  doi: 10.1084/jem.186.7.1129
– ident: 15
  doi: 10.1038/370151a0
– ident: 30
  doi: 10.1038/icb.2008.5
– volume: 62
  start-page: 3404
  issue: 11
  year: 2010
  ident: 72
  publication-title: Arthritis & Rheumatism
  doi: 10.1002/art.27677
– volume: 58
  start-page: 1691
  issue: 10
  year: 2009
  ident: 38
  publication-title: Cancer Immunology, Immunotherapy
  doi: 10.1007/s00262-009-0680-0
– ident: 40
  doi: 10.1111/j.1365-2249.2004.02686.x
– ident: 28
  doi: 10.1074/jbc.270.24.14679
– volume: 22
  start-page: 405
  year: 2004
  ident: 48
  publication-title: Annual Review of Immunology
  doi: 10.1146/annurev.immunol.22.012703.104711
– ident: 34
  doi: 10.1084/jem.20021127
– volume: 182
  start-page: 829
  issue: 2
  year: 2009
  ident: 64
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.182.2.829
– ident: 6
  doi: 10.1158/1078-0432.CCR-03-0683
– ident: 37
  doi: 10.1111/j.1365-3083.2010.02395.x
– ident: 3
  doi: 10.1016/S0301-472X(98)00055-1
– ident: 44
  doi: 10.1006/geno.2000.6163
– volume: 170
  start-page: 4572
  issue: 9
  year: 2003
  ident: 21
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.170.9.4572
– ident: 47
  doi: 10.1038/nri2154
– ident: 62
  doi: 10.1002/eji.1830270612
– ident: 17
  doi: 10.1038/370153a0
– volume: 170
  start-page: 481
  issue: 2
  year: 1989
  ident: 19
  publication-title: Journal of Experimental Medicine
  doi: 10.1084/jem.170.2.481
– volume: 172
  start-page: 2152
  issue: 4
  year: 2004
  ident: 60
  publication-title: Journal of Immunology
– ident: 73
  doi: 10.1016/j.jim.2004.08.008
– ident: 12
  doi: 10.1155/MI/2006/46957
– volume: 171
  start-page: 1768
  issue: 4
  year: 2003
  ident: 36
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.171.4.1768
– ident: 7
  doi: 10.1186/1479-5876-7-50
– volume: 171
  start-page: 6611
  issue: 12
  year: 2003
  ident: 32
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.171.12.6611
– ident: 29
  doi: 10.1038/sj.icb.7100031
– ident: 67
  doi: 10.1016/j.jri.2005.12.008
– volume: 68
  start-page: 3519
  issue: 21
  year: 2011
  ident: 46
  publication-title: Cellular and Molecular Life Sciences
  doi: 10.1007/s00018-011-0797-0
– volume: 12
  start-page: 1165
  issue: 5
  year: 1998
  ident: 63
  publication-title: International Journal of Oncology
– ident: 9
  doi: 10.1038/ni1581
– ident: 49
  doi: 10.1073/pnas.92.2.377
– volume: 161
  start-page: 3493
  issue: 7
  year: 1998
  ident: 14
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.161.7.3493
– ident: 55
  doi: 10.1093/neuonc/nop009
– volume: 176
  start-page: 2397
  issue: 4
  year: 2006
  ident: 68
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.176.4.2397
– ident: 20
  doi: 10.1034/j.1399-0039.2003.00037.x
– ident: 71
  doi: 10.1158/0008-5472.CAN-11-1565
– volume: 176
  start-page: 6270
  issue: 10
  year: 2006
  ident: 5
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.176.10.6270
– volume: 265
  start-page: 1573
  issue: 5178
  year: 1994
  ident: 24
  publication-title: Science
  doi: 10.1126/science.8079170
– ident: 54
  doi: 10.1016/j.exphem.2010.02.006
– volume: 168
  start-page: 3155
  issue: 7
  year: 2002
  ident: 52
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.168.7.3155
– ident: 11
  doi: 10.1007/s12192-007-0008-y
– volume: 4
  start-page: 573
  issue: 6
  year: 2006
  ident: 69
  publication-title: Immunity
– volume: 153
  start-page: 2417
  issue: 6
  year: 1994
  ident: 45
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.153.6.2417
– volume: 254
  start-page: 3692
  issue: 10
  year: 1979
  ident: 27
  publication-title: Journal of Biological Chemistry
  doi: 10.1016/S0021-9258(18)50638-4
– ident: 53
  doi: 10.1182/blood-2002-04-1251
– ident: 23
  doi: 10.1016/j.humimm.2010.06.015
– ident: 1
  doi: 10.1038/sj.onc.1202525
– volume: 2
  start-page: 321
  issue: 4
  year: 1995
  ident: 16
  publication-title: Immunity
  doi: 10.1016/1074-7613(95)90140-X
– ident: 61
  doi: 10.1182/blood.V98.3.705
– ident: 31
  doi: 10.1016/j.coi.2004.07.010
– volume: 308
  start-page: 693
  issue: 5961
  year: 1984
  ident: 26
  publication-title: Nature
  doi: 10.1038/308693a0
– ident: 43
  doi: 10.1007/s002510050276
– ident: 10
  doi: 10.2217/imt.11.102
– ident: 66
  doi: 10.1016/S0022-1759(02)00084-4
– ident: 74
  doi: 10.1016/j.cellimm.2008.08.007
– ident: 58
  doi: 10.1007/s002510050362
– volume: 2
  start-page: 689
  issue: 6
  year: 1995
  ident: 18
  publication-title: Immunity
  doi: 10.1016/1074-7613(95)90013-6
– volume: 158
  start-page: 4341
  issue: 9
  year: 1997
  ident: 2
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.158.9.4341
– ident: 65
  doi: 10.1016/S1074-7613(02)00427-2
– ident: 70
  doi: 10.1074/jbc.M601786200
– volume: 171
  start-page: 3415
  issue: 7
  year: 2003
  ident: 35
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.171.7.3415
– ident: 50
  doi: 10.1038/ni1487
– volume: 171
  start-page: 5277
  issue: 10
  year: 2003
  ident: 57
  publication-title: Journal of Immunology
  doi: 10.4049/jimmunol.171.10.5277
– ident: 22
  doi: 10.1002/eji.200737266
– ident: 51
  doi: 10.1038/ni1524
– volume: 78
  start-page: 75
  issue: 1
  year: 1987
  ident: 8
  publication-title: Acta Haematologica
  doi: 10.1159/000205907
SSID ssj0005448
Score 2.1533093
Snippet NK cells represent a potential tool for adoptive immunotherapy against tumors. Membrane-bound Hsp70 acts as a tumor-specific marker enhancing NK cell activity....
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
hindawi
emarefa
airiti
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 263
SubjectTerms Antigens, Differentiation, T-Lymphocyte - metabolism
Cells, Cultured
Health aspects
Heat shock proteins
HSP70 Heat-Shock Proteins - chemistry
Humans
Interleukin-15 - pharmacology
Interleukin-2 - pharmacology
Interleukins
Killer cells
Killer Cells, Natural - drug effects
Killer Cells, Natural - metabolism
Leukocytes, Mononuclear - drug effects
Leukocytes, Mononuclear - metabolism
Lysosomal Membrane Proteins - metabolism
Natural Cytotoxicity Triggering Receptor 1 - metabolism
Natural Cytotoxicity Triggering Receptor 2 - metabolism
Natural Cytotoxicity Triggering Receptor 3 - metabolism
NK Cell Lectin-Like Receptor Subfamily B - metabolism
NK Cell Lectin-Like Receptor Subfamily C - metabolism
NK Cell Lectin-Like Receptor Subfamily K - metabolism
Peptides
Peptides - chemistry
Peptides - pharmacology
Receptors, IgG - metabolism
Receptors, KIR2DL2
Receptors, KIR2DL4 - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXxKsQKMiISjykqBu_Eh-XPrRLadVDi3qznMTRRlqSKrtt4QfxP5lxvKumquDCKfJm1rFnJuNv4vEMIdsA61XpChfnSstYMKfgnUt1rIWQVlaWOZ9n9uhYTc7E13N5fqPUF8aE9emBe8btZA5rZOVYfrUS2jGrq6worbQF55ViHhrBmrdyplbBHcLXzQJ8zmLNZRJO5sHiCd5-wneE3-CCVcfWmDtosCj53P3-gK6Ftl3b6vsz9JKv67uw6O2Qyhtr1MFj8iiASzruJ_WE3HPNU_LgKGyfPyO_p6uSJLSt6LSh3-tl19Lpt5jRtsNrIul43jYOm3VDwVqA5-yFR_GLLZ0sLuJ0FO-B3l65kiYi_uE6eoKhMaWjH08P9z5RoAVUSfd_hhjbBh92fEh33RzGVvh6am33i9qmhDHM6rz2TQCw0E3bLZ6Ts4P9091JHOo0xBbQ1DK24LRJXWiZcgsWQlidVXmlwBXKZJoDoJFV6rTjznGgGIHwSpCmVXnK4f9W8E2y0cDUXhKqimqkNHjspeVCFCpHOTNmYRW1irE8ItNeYia8agtzwjBJnsQNdG5QuAnDC1oyDEC53VBAlAoDsCYin1dCN0VIiI51OebGO0ZS-t5MryoR2V4TX_R5QO4m-4LasybB5N3-B1BpE1Ta_EulI7IZdG_dj1BaqCQiH1AVDdoeGGlhwxEK4B1m8TJjzB6pUwBlEdkaUILNKAa33wdl_vtk3q0U3WAHGI7XuPZyYYDJwHLFE-jpRa_4644YFylgcmBvOnglBjwZ3mnqmU9szmWWAZx99T-Y-Jo8ZL5yCX4t2yIby-7SvQH8uMzfelPxB338Xvc
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3rb9MwELfYJBBfEK9BYCAjJvGQojV-Jf5Y9lDL2LQPG-o3y0kcNVJJprTj8Qfxf3LnuoWUCfEpcnO52ufz-Xfx5Y6QPYD1qnSFi3OlZSyYU7DmUh1rIaSVlWXO55k9PVOjS_FxIichQHb-9xE-7Hbgnid8X_gTqS2yBfqFPvlo8juQQ_gaWYDFWay5TMJXeBuPwg5ja8wT1NuAfJ5-_zGuhbZd2-XbU_SIv9U34c7N8Mk_9qPj--ReAJJ0uJz5B-SWax6SO6fhqPwR-TlelR-hbUXHDf1cL7qWjj_FjLYdXhNJh7O2cdisGwqWAbxkP1EU387S0fwqTgfxIejoV1fSRMRfXEfPMQymdPTtxcnhOwq0gCDp0fcQT9vgn52d0AM3g74VvnZa2_2gtimhD9M6r30TwCqwabv5Y3J5fHRxMIpDTYbYAnJaxBYcNKkLLVNuwRoIq7MqrxS4PZlMcwAvskqddtw5DhSD0soSEIJVecrheSv4DtluYGhPCVVFNVAavPPSciEKlUtbgHmxsGNaxVgekfFyxkxYVnNzzjAhnsTDcm5wchOGF7RaGGyy2VBAlAoDECYi71eTboqQ_BxrcMyMd4Kk9NzMUlUisrcmvlrm_LiZ7ANqz5oEE3X7H0B5TVj3JnNY4i3H6sGV0I5ZXWUFSAWGyivFbER2gu6t-QilhUoi8gZV0aCdgZ4WNnwuAbLDjF1miJkidQoALCK7PUqwD0Xv9uugzP8ezKuVohtkgKF3jWuv5waEDCJXPAFOT5aKv2bEuEgBf4N4096S6Mmkf6eppz6JOZdZBtD12X_17jm5y3wZEnz1tUu2F921ewFgcJG_9LbgF2heS0Q
  priority: 102
  providerName: Hindawi Publishing
Title Influence of In Vitro IL-2 or IL-15 Alone or in Combination with Hsp-70-Derived 14-mer Peptide (TKD) on the Expression of NK Cell Activatory and Inhibitory Receptors
URI https://www.airitilibrary.com/Article/Detail/P20160527003-201312-201703020022-201703020022-263-274-124
https://search.emarefa.net/detail/BIM-469461
https://dx.doi.org/10.1155/2013/405295
https://www.ncbi.nlm.nih.gov/pubmed/23476104
https://www.proquest.com/docview/1316056311
https://pubmed.ncbi.nlm.nih.gov/PMC3588175
https://doaj.org/article/8e4179b2152f49e2a9f8cda5ac33f62a
Volume 2013
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1rb9Mw0BrjIb4gXoPAqIyYxEMKNPEj8QeEyh5qKZ0mtE79ZjmJQyOVZKQdbD-I_8mdmxZaVXzgSyM354t9vjvf-XFHyB6Y9TKzqfUTqYTPQytB5iLlK86FEbkJrYszOziW3SH_NBKjLbJIxtkQcLrRtcN8UsN68vby-9UHEPj3TuCFAP89YO-427K6Rq7DlBShhA74n7Dhgrs0WmCuh75iImgu6q1VxsDAjINfj1nbbpgCowqtTFcuqr-7umugbJZa_OYY_eefxSYrdf2w5V-z19FdcqcxO2lnzif3yJYt75Nbg2Zj_QH51VskK6FVTnslPStmdUV7n_2QVjU-A0E7k6q0WCxKCnoEfGo3rBTXcml3eu5Hbf8AOPqHzWjA_W-2pid4aCaz9NVp_-A1BViwN-nhZXP6tsSPHffpvp1A21KXaa2qr6gpM2jDuEgKVwTTFtBU9fQhGR4dnu53_SaDg2_Azpr5Btw5oVIlImZAd3Cj4jzJJThJsYgSMHVEHlllmbUMINqZERnYE0YmEYP6hrMdsl1C1x4TKtO8LRX48plhnKcyESYFZWRgfjUyDBOP9OYjphc8pE9CDJ8ncGudaRznIMQH6jg8mrJekAAUcQ0Gj0feLAZdp02odMzYMdHOZRLCYdNzrvHI3hL4fB4hZDPYR-SeJQiG9XZ_VPVX3WgJHVtMCJdgruGcKxsalccpUAW6ynIZGo_sNLy3xMOl4jLwyEtkRY1yAi1NTXO5AmiH8b10B-NKqghkwyO7K5CgTdKV1y8aZv53Z54vGF0jAjyoV9rqYqqByEByyQLA9GjO-EtEC-HySLQiEis0WX1TFmMX8pyJOAZD98l_13xKbocukQkunu2S7Vl9YZ-BOTlLWuBI9fottxjTcmoDfr90R78BfhNn0A
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influence+of+In+Vitro+IL-2+or+IL-15+Alone+or+in+Combination+with+Hsp-70-Derived+14-mer+Peptide+%28TKD%29+on+the+Expression+of+NK+Cell+Activatory+and+Inhibitory+Receptors&rft.jtitle=Mediators+of+inflammation&rft.au=Hromadnikova%2C+Ilona&rft.au=Pirkova%2C+Petra&rft.au=Sedlackova%2C+Lucie&rft.date=2013-01-01&rft.pub=Hindawi+Publishing+Corporation&rft.issn=0962-9351&rft.eissn=1466-1861&rft.volume=2013&rft_id=info:doi/10.1155%2F2013%2F405295&rft_id=info%3Apmid%2F23476104&rft.externalDocID=PMC3588175
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0962-9351&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0962-9351&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0962-9351&client=summon